Buy Reglan

Reglan

RegLan: Metoclopramide Overview

RegLan is a brand-name medication that contains the active ingredient metoclopramide. Metoclopramide belongs to the class of prokinetic agents used to treat various digestive-health conditions. In Hong Kong, RegLan is available only with a prescription and is supplied as a 10 mg tablet.

How Metoclopramide Works in the Body

Metoclopramide exerts its therapeutic effect through two primary mechanisms:

• Dopamine D₂-receptor antagonism in the chemoreceptor trigger zone of the brain reduces the sensation of nausea and vomiting.
• Enhancement of gastrointestinal motility by increasing the responsiveness of the upper gastrointestinal tract to acetylcholine, which promotes coordinated muscle contractions that move food through the stomach and intestines more efficiently.

These actions result in a faster gastric emptying rate and less reflux of stomach contents into the esophagus. Oral tablets are rapidly absorbed, reaching peak plasma concentrations within 1-2 hours. The drug is largely metabolized in the liver and eliminated in the urine, with a plasma half-life of roughly 5-6 hours.

Conditions Treated with RegLan

RegLan (metoclopramide) is approved in Hong Kong for the following indications:

• Nausea and vomiting associated with postoperative recovery, chemotherapy, and migraine.
• Gastro-esophageal reflux disease (GERD) when symptoms are not adequately controlled by standard acid-suppression therapy.
• Gastroparesis (delayed stomach emptying) in adults, particularly when caused by diabetic neuropathy or idiopathic dysfunction.

These uses reflect the drug’s dual anti-emetic and prokinetic properties. The typical patient is an adult who requires symptomatic relief from nausea or needs improved gastric motility to facilitate digestion.

Evidence-Based Off-Label Uses

• Lactation promotion - Some clinical studies have shown that metoclopramide can increase prolactin levels and thereby enhance breast-milk production. This use is not approved by the Hong Kong Department of Health and should only be considered under close medical supervision because of the risk of neurologic side effects.

Disclaimer: Off-label use requires individualized risk assessment and close monitoring by a qualified healthcare professional.

Who Should Use RegLan? Contra-indications and Precautions

Absolute Contra-indications

• Known hypersensitivity to metoclopramide or any excipients in the tablet.
• Pseudoparkinsonism or any condition that predisposes to extrapyramidal movement disorders.
• Severe hepatic impairment (the drug’s metabolism is significantly reduced).
• Use in pregnancy beyond the first trimester is contraindicated due to evidence of fetal harm.

Relative Contra-indications

• Renal insufficiency - dose adjustment may be needed.
• Elderly patients - increased sensitivity to central nervous system effects; monitor closely for confusion or dizziness.
• History of seizure disorders - metoclopramide can lower the seizure threshold.

Special Populations

• Breastfeeding - short-term use may be permissible, but long-term exposure is discouraged.
• Pediatric use - not recommended for children under 18 years for most indications because of heightened risk of extrapyramidal reactions.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Drowsiness or fatigue (often described as “tiredness”).
• Restlessness or mild agitation.
• Diarrhea or abdominal cramping due to increased gut motility.

These effects are usually transient and lessen as the body adjusts to the medication.

Serious Adverse Events

• Extrapyramidal symptoms (e.g., acute dystonia, akathisia) that may appear within the first few days of therapy. Immediate medical evaluation is required.
• Tardive dyskinesia, a potentially irreversible movement disorder, especially after prolonged treatment (>12 weeks).
• Neuroleptic malignant syndrome - rare but life-threatening; characterized by high fever, muscle rigidity, and altered mental status.

If any of these serious reactions occur, discontinue RegLan and seek urgent care.

Drug Interactions

• CYP2D6 substrates (e.g., codeine, tramadol) - metoclopramide can inhibit metabolism, increasing plasma levels of these agents.
• Anticholinergic drugs (e.g., atropine, scopolamine) - may reduce the prokinetic effect of metoclopramide.
• Other dopamine antagonists (e.g., antipsychotics) - additive risk of extrapyramidal side effects.

Patients should inform their prescriber about all current medications, over-the-counter products, and herbal supplements.

Food and Lifestyle Interactions

• Metoclopramide can be taken with or without food; however, taking it with a small amount of food may lessen gastrointestinal upset.
• Alcohol does not have a known pharmacokinetic interaction, but excessive consumption can exacerbate drowsiness.
• Caution when driving or operating machinery until the individual knows how the medication affects them.

How to Take RegLan

• Standard dosing - The usual adult regimen starts with 10 mg taken orally 30 minutes before meals and at bedtime, up to four times per day. The total daily dose should not exceed 40 mg.
• Renal or hepatic impairment - Dose may need to be reduced; a physician will determine the appropriate adjustment.
• Tablet administration - Swallow the tablet whole with a glass of water; do not crush or chew, as this can affect drug absorption.
• Missed dose - If a dose is missed, take it as soon as remembered unless the next scheduled dose is within a few hours. Do not double the dose.
• Overdose - Symptoms may include severe drowsiness, agitation, or seizures. Seek emergency medical attention; supportive care is the mainstay of treatment.
• Discontinuation - If therapy is to be stopped after prolonged use, gradual tapering over several days is advisable to lower the risk of withdrawal dyskinesia.

Monitoring and Follow-Up

• Neurologic assessment - Patients on metoclopramide for more than 12 weeks should have periodic evaluations for early signs of tardive dyskinesia.
• Renal and hepatic function - Baseline labs are recommended before initiating therapy; repeat testing may be needed for patients with known organ dysfunction.
• Blood glucose - In diabetic patients, improved gastric emptying can affect glucose control; monitor blood sugar levels accordingly.

Regular follow-up appointments enable clinicians to adjust dosing, assess efficacy, and identify adverse effects early.

Storage and Handling

• Keep tablets at room temperature (15 °C - 30 °C).
• Protect from moisture and direct sunlight.
• Keep the container tightly closed and out of reach of children.
• Do not use the medication after the expiration date printed on the package.
• Dispose of unused tablets according to local pharmacy-take-back programs or the instructions on the label.

Medication-Specific Glossary

Extrapyramidal symptoms

Unwanted movements such as muscle rigidity, tremor, or involuntary muscle contractions caused by dopamine antagonism in the central nervous system.

Tardive dyskinesia

A potentially irreversible disorder characterized by repetitive, involuntary movements, often of the face and tongue, that can arise after long-term use of dopamine-blocking agents.

Prokinetic

A drug that enhances gastrointestinal motility, facilitating the movement of contents through the digestive tract.

D₂-receptor antagonist

A substance that blocks dopamine D₂ receptors, reducing nausea signals from the brain’s chemoreceptor trigger zone.

Medical Disclaimer

This article provides educational information about RegLan and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.